Entero Therapeutics, Inc. (ENTO) — Defensive Interval Ratio
Entero Therapeutics, Inc. (ENTO) has a Defensive Interval Ratio of 0 days as of September 2025. Defensive assets of $37.49K (cash $-, short-term investments $-, receivables $37.49K) cover 0 days of daily cash needs of $91.83K/day. See working capital position of Entero Therapeutics, Inc. to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Entero Therapeutics, Inc. Defensive Interval Ratio (2014–2022)
This chart shows how Entero Therapeutics, Inc.'s Defensive Interval Ratio has evolved across 8 annual periods from 2014 to 2022. As of September 2025, the ratio stands at 0 days, meaning defensive assets of $37.49K can fund 0 days of operations without new revenue. Read Entero Therapeutics, Inc. (ENTO) financial obligations for a breakdown of total debt and financial obligations.
Annual Defensive Interval Ratio for Entero Therapeutics, Inc. (2014–2022)
The table below presents the year-by-year Defensive Interval Ratio for Entero Therapeutics, Inc. from 2014 to 2022, covering 8 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see Entero Therapeutics, Inc. total assets.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2022 | 14 days | $93.01K | $6.80K/day | $- | $- | ▲ +1 days |
| 2020 | 13 days | $551.49K | $42.59K/day | $- | $- | ▼ -212 days |
| 2019 | 225 days | $2.64 Million | $11.74K/day | $- | $- | ▼ -162 days |
| 2018 | 387 days | $3.17 Million | $8.21K/day | $- | $- | ▲ +343 days |
| 2017 | 44 days | $298.47K | $6.79K/day | $- | $- | ▼ -106 days |
| 2016 | 150 days | $961.04K | $6.41K/day | $- | $- | ▲ +105 days |
| 2015 | 45 days | $1.07 Million | $24.15K/day | $- | $56.85 | ▼ -20 days |
| 2014 | 64 days | $428.88K | $6.66K/day | $- | $125.07 | — |